Last reviewed · How we verify
Placebo of Bronpass Tab.
A placebo formulation containing no active pharmaceutical ingredient, used as a control in clinical trials or as a reference standard.
At a glance
| Generic name | Placebo of Bronpass Tab. |
|---|---|
| Sponsor | Kwang-Ha Yoo |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Placebo products contain inert ingredients and produce no pharmacological effect. They are used in clinical research to establish baseline efficacy through comparison with active treatments, or may be marketed as over-the-counter products with minimal therapeutic claims. This particular placebo is associated with Bronpass Tab branding.
Approved indications
Common side effects
Key clinical trials
- Study to Evaluate Efficacy and Safety of Bronpass Tab. in Patients With Chronic Obstructive Pulmonary Disease (PHASE2)
- Evaluate the Efficacy and Safety of Acute Bronchitis Symptoms Improvement for Bronpass Tab. Compared to Erdos Capsule (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo of Bronpass Tab. CI brief — competitive landscape report
- Placebo of Bronpass Tab. updates RSS · CI watch RSS
- Kwang-Ha Yoo portfolio CI